Cancers

First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers

Two compounds that zero in on cancer cells spreading throughout the body, while ignoring primary tumor cells, could someday give doctors a whole new weapon in the fight against tough-to-treat metastatic disease, according to Weill Medical College of Cornell University researchers. The compounds, called synthetic migrastatin analogues, prevented 91 to 99 percent of metastatic breast cancer...

Towards precise classification of cancers based on robust gene functional expression profiles

Chemists say they have identified a gene that appears to play a key role in the development of type 1 diabetes, also known as insulin-dependent or juvenile diabetes, a disease that affects about one million people in the U.S. and is on the rise worldwide. They described their findings, which they say could lead to new drug interventions and possibly gene therapy, today at the 229th national meeti...

Epstein-Barr virus protein crucial to its role in blood cancers

Researchers at the University of Pennsylvania School of Medicine have identified a link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein known to be expressed in a number of EBV-associated cancers. Their findings demonstrate a new mechanism by which EBV transforms human B cells from the immune system into cancerous cells, which can lead to development of B-cell lymphomas....

Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute. Studies of people with acquired immunodeficiency syndrome (AIDS) have reported increased risks of several cancers, in...

Study reveals dramatic difference between breast cancers in US and Africa

A study comparing, for the first time, breast cancers from Nigeria, Senegal and North America has found that women of African ancestry are more likely to be diagnosed with a more virulent form of the disease than women of European ancestry. Researchers from the University of Chicago, working with colleagues at the University of Calabar in Nigeria and the University of North Carolina, foun...

More>>

Cancers at Biology Products

No data found

Search Cancers biology products at Google

Search Cancers biology products at Yahoo

Search Cancers biology products at Msn

Cancers at Biology Technology

No data found

Search Cancers biology technology at Google

Search Cancers biology technology at Yahoo

Search Cancers biology technology at Msn

Cancers at Medicine News

Vitamin B12 can help in detecting cancers

In some of the cancer patients the Tumors can't be easily deected. A new procedure being done at Mayo Clinic using vitamin B12 that helps doctors locate hard to find tumors. During the processes a patient is injected with radioactive vitamin B12. After three hours a gamma camera takes pictures of the body. Dr. Collins treated a patient with breast cancer and he says that, "The cancer stands out a...

Cancers of Colon & Rectum linked to Cigarette Smoking

The risks of smoking are well known. Besides causing 160,000 deaths annually from lung, mouth, bladder and other cancers, smoking also increases the risk of death from cancer of the colon or rectum, according to results of a large new study from the American Cancer Society. As many as 12% of all colorectal cancer deaths in the US may be caused by tobacco smoking. "Colorecta...

Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis

The sad part in the treatment of certain cancers, hepatitis and multiple sclerosis with interferon therapy is that while the treatment can extent life, it can seriously spoil its quality. Alpha interferon a drug used to fight these diseases can cause crippling depression. A new research now shows that the use of an antidepressant before starting the treatment can avoid this problem. Al...

Exercises reduce risks of cancers

Taking regular exercise is likely to decrease the chances of getting bowel cancer, say scientists. Swedish experts have gathered up all the evidence on the issue, and say that it points more firmly than ever to this conclusion. The research, carried out by the Cancer Research Campaing and Swedish Cancer Foundation, combined and analysed the results of more than 60 separate studies int...

BRAC2 mutations is also linked with cancers in men

Dutch researchers have published the results of their work linking mutations in BRAC2 gene leading to development of cancers in men, which was published in the Journal of Medical Ethics. //Mutations in BRAC2 gene which was found to cause development of breast and ovarian cancer in women has now found to increase the risk of development of pancreatic and prostate cancers in men. The results of the...

More>>

Cancers at Medicine Products

Cochrane Reviews in Prostatic Diseases and Urologic Cancers

Description:Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source available for continually updated evidence-based medical information. Each review explores the evid...
Company:Skyscape, Inc.

Cancers at Medicine Technology

Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers

WASHINGTON, January 29, 2007 /PRNewswire-USNewswire/ -- RearAdmiral Timothy Ziemer (U.S. Navy, retired), the President'sMalaria Coordinator, announced his intent to name Dr. BernardNahlen to serve as Deputy Coordinator of the President's MalariaInitiative (PMI). Dr. Nahlen is a Commissioned Officer in the U.S.Public Heath Service and has most recently served as SeniorAdvisor, Monitoring...

Publication Confirms that EpCAM, the Target for Two of Micromet's Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers

BETHESDA, Md., June 26, 2007 /PRNewswire-FirstCall/ -- Micromet,Inc. , a biopharmaceutical company focusing on the development ofnovel, proprietary antibody-based products for cancer, inflammatoryand autoimmune diseases, announced that a study published recentlyin the Proceedings of the National Academy of Sciences (1) supportsthe findings of several other studies that EpCAM (CD326), whic...

Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO

Clinical Benefit Shown in 35% of HER2-Positive Metastatic BreastCancer Patients HAYWARD, Calif., June 04, 2007 /PRNewswire-FirstCall/ -- KosanBiosciences Incorporated presented data from a Phase 1 clinicaltrial showing that alvespimycin, its second-generation Hsp90inhibitor, demonstrated promising antitumor activity andtolerability in combination with trastuzumab (Herceptin(R)) inpatient...

Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers

- Company Planning to Initiate Phase 2 Trials in Colorectal Cancerand in Hormone-Refractory Prostate Cancer in Q307 - SOUTH SAN FRANCISCO, Calif., June 01, 2007/PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , abiopharmaceutical company focused on oncology, today announcedpromising results from an interim safety analysis of two Phase 1dose-escalating trials of picoplatin, a new ge...

Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers

- Journal of Clinical Oncology publishes first clinical study ofHGS-ETR1 - ROCKVILLE, Md., April 27, 2007 /PRNewswire-FirstCall/ -- HumanGenome Sciences, Inc. today reported that clinical and preclinicalevidence continues to emerge demonstrating that its TRAIL receptorantibodies, HGS-ETR1 (mapatumumab) and HGS-ETR2 (lexatumumab), havesignificant potential for use in the treatment of a bro...

More>>

Cancers at Medicine Dictionary

Oral cancers

s and <a href="/ ?q=/ Medici...